Document is current
Any future updates will be listed below
-
Authors
Liang, Feiyan https://orcid.org/0000-0003-2635-0685
Xie, Yuman https://orcid.org/0000-0001-5612-123X
Zhang, Chi
Zhao, Yong https://orcid.org/0000-0002-0423-5232
Motawia, Mohammed S. https://orcid.org/0000-0001-5582-9463
Kampranis, Sotirios C. https://orcid.org/0000-0001-6208-1684
-
Funding
Funding for this research was provided by:
Teknologi og Produktion, Det Frie Forskningsråd (0136-00410B)
Novo Nordisk Fonden (NNF19OC0055204, NNF20OC0064680)
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 31 March 2025
First Online: 30 April 2025
Competing interests
: F.L., Y.X., C.Z., Y.Z. and S.C.K. are co-inventors on two patent applications disclosing the use of T2′OGD and T3′NBT for the biotechnological production of paclitaxel (PCT/EP2024/088095 and EP24386083.0). M.S.M. declares no commercial or non-commercial interests.
